scholarly journals Psychosocial and functional outcomes in long-term survivors of osteosarcoma: A comparison of limb-salvage surgery and amputation

2010 ◽  
Vol 54 (7) ◽  
pp. 990-999 ◽  
Author(s):  
Rhonda S. Robert ◽  
Giulia Ottaviani ◽  
Winston W. Huh ◽  
Shana Palla ◽  
Norman Jaffe
1998 ◽  
Vol 5 (5) ◽  
pp. 423-436 ◽  
Author(s):  
S. John Ham ◽  
Heimen Schraffordt Koops ◽  
René P. H. Veth ◽  
Jim R. van Horn ◽  
Willemina M. Molenaar ◽  
...  

2001 ◽  
Vol 37 ◽  
pp. S86
Author(s):  
G. Delepine ◽  
F. Delepine ◽  
S. Alkallaf ◽  
B. Markowska ◽  
N. Delepine

2020 ◽  
Author(s):  
Donnel Alexis Ting Rubio ◽  
Katsuhiro Hayashi ◽  
Norio Yamamoto ◽  
Toshiharu Shirai ◽  
Akihiko Takeuchi ◽  
...  

Abstract Background: Segmental metallic endoprostheses are widely used and important in reconstructive procedures of the lower limb. Most of the currently available endoprostheses are made in Europe or the United States of America and are too large for Asian knees. The Japanese Musculoskeletal Oncology Group developed a tumor prosthesis better suited for Asian skeletal anatomy, the Kyocera Modular Limb Salvage System (KLS).Methods: We performed a retrospective review of the records of patients who underwent reconstruction using KLS implants. Thirty-five patients fulfilled the inclusion criteria, 20 having undergone limb salvage surgery for tumor and 15, joint arthroplasty. Functional outcomes were evaluated using the revised Musculoskeletal rating scale for the tumor group and the Japanese Orthopedic Association Knee Score for the arthroplasty group. Complications and survivorship of the implants were also assessed.Results: At the latest follow-up, in the tumor group, 13 were alive with no evidence of recurrence, 6 died of disease, and 1 was alive with evidence of disease. The average MSTS scores on latest follow-up were 63 for the proximal femur, 67 for the distal femur, and 92 for the proximal tibia. The mean prosthesis survival was 28 months. Complications include 4 cases of aseptic loosening, 2 deep infections, 1 superficial infection, 1 valgus deformity, 2 periprosthetic fractures, 2 incidences of excessive polyethylene wear, and 2 local tumor recurrences. In the arthroplasty group, 1 patient had a persistent low grade infection on the latest follow-up. The post-operative JOA score was 61(mean). Complications included 3 cases of aseptic loosening, 2 deep infections, 2 implant failures, 1 superficial infection, 1 valgus deformity, and 1 soft tissue defect.Conclusion: Early results of the KLS implant system are encouraging, with comparable clinical outcomes to other systems in the literature. A longer follow-up study with increased numbers of patients is necessary to further validate the functional outcomes and prosthesis survival using the KLS system for limb salvage surgery.


2009 ◽  
Vol 90 (6) ◽  
pp. 1039-1047 ◽  
Author(s):  
Kathleen Beebe ◽  
Kimberly J. Song ◽  
Ellen Ross ◽  
Benjamin Tuy ◽  
Francis Patterson ◽  
...  

2021 ◽  
Vol 3 (2) ◽  
Author(s):  
Daniela Kristina D. Carolino ◽  
Edwin Joseph R. Guerzon ◽  
Richard S. Rotor

Giant cell tumor of the bone (GCTB) is a benign, locally aggressive neoplasm that is relatively rare, with a propensity to result in progressive bone destruction, and is associated with a high risk of recurrence. There is no widely held consensus regarding its ideal treatment. Worldwide, there are varying techniques ranging from intralesional curettage to resection of the lesion, supplemented with combinations of numerous adjuncts and fillers, depending on the resected amount and integrity of bone, as well as the preference of the surgeon. This was a cross-sectional study that included 20 patients who underwent limb salvage surgery for giant cell tumor of the bone of the lower extremities from January 2009 to February 2020 at two tertiary hospitals. The mean follow-up period was 37.3 months (SD=2.84). The extended curettage (EC) group had a mean Musculoskeletal Tumor Rating Scale (MSTS) score of 28.18 (SD=7.51) which is considered as an excellent outcome, while the resection (RS) group had an mean MSTS score of 19.67 (SD=11.02), which is considered as a good outcome. EC resulted to a total of eight complications (47%), while RS had one complication (33%). Prevalence of recurrence was noted to be 11.75% among those who underwent EC, while no recurrence was noted among those in the RS group. Use of bone cement as a filler was noted to have less recurrence as compared with the use of bone grafts, however were both were noted to result in excellent functional outcomes. Despite the prevalence of complications and recurrence of GCTB of the salvaged extremity in those who underwent EC, there is still report of excellent functionality. It is hence important to disclose all these possible outcomes and to stress the importance of compliance to follow-up for monitoring of these events.


2020 ◽  
Vol 12 (23) ◽  
pp. 189-194
Author(s):  
Manish R Shah ◽  
Manisha M Shah ◽  
Aditya K. Agrawal ◽  
Malkesh D Shah ◽  
Sarvang M Desai

Sign in / Sign up

Export Citation Format

Share Document